US Equities insigtX

Moderna Just the Start: Why AI Capital May Flow into Biotech

Don Vandenbord of Revere Asset Management believes Moderna's stock could attract investors interested in AI opportunities. He stated that the potential for AI-focused investments to enter the biotech…

Published
Market
US Equities
Source
insigtX

Don Vandenbord of Revere Asset Management believes Moderna's stock could attract investors interested in AI opportunities. He stated that the potential for AI-focused investments to enter the biotech sector is substantial. This view could lead to further growth in Moderna's stock and AI-related investments within the biotech space.

Original: https://www.investors.com/news/moderna-stock-start-of-ai-focused-money-in-biotech/

insigtX content is informational and educational, not investment advice.